PANE, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 87
EU - Europa 24
AS - Asia 3
Totale 114
Nazione #
US - Stati Uniti d'America 86
IE - Irlanda 6
IT - Italia 6
GB - Regno Unito 4
FR - Francia 3
VN - Vietnam 3
DE - Germania 2
CA - Canada 1
PL - Polonia 1
RU - Federazione Russa 1
UA - Ucraina 1
Totale 114
Città #
Santa Cruz 12
Cambridge 6
Dublin 6
Ashburn 5
Fairfield 5
Seattle 4
Woodbridge 4
Bologna 3
Buffalo 3
Chicago 3
Southend 3
Boardman 2
Houston 2
San Diego 2
Wilmington 2
Ann Arbor 1
Cheyenne 1
Dong Ket 1
Fleming Island 1
Frankfurt Am Main 1
Hamilton 1
Henderson 1
Jacksonville 1
Las Vegas 1
Los Angeles 1
Lugo 1
Munich 1
New York 1
Pieve di Cento 1
Redmond 1
Reston 1
Rome 1
Totale 79
Nome #
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia, file e1dcb330-4aea-7715-e053-1705fe0a6cc9 52
Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case report, file e1dcb336-638c-7715-e053-1705fe0a6cc9 50
One-Step Quantitative Molecular Approach for Detection of BCR/ABL1 Rearrangement and for Monitoring of Minimal Residual Disease in CML Patients: An Inter Laboratory Study, file e1dcb330-fdbf-7715-e053-1705fe0a6cc9 5
Evaluation of Cepheid Xpert® BCR-ABL Monitor Assay in Three Italian Reference Centers for Monitoring of BCR-ABL Transcript Levels in CML Patients, file e1dcb330-c2db-7715-e053-1705fe0a6cc9 4
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia, file e1dcb335-14cf-7715-e053-1705fe0a6cc9 4
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia, file e1dcb336-c3f5-7715-e053-1705fe0a6cc9 2
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study, file 66426d0c-4b81-4c86-a3d7-41ca0ba4c33e 1
null, file e1dcb32e-d9f4-7715-e053-1705fe0a6cc9 1
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis, file e1dcb334-5266-7715-e053-1705fe0a6cc9 1
Totale 120
Categoria #
all - tutte 341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 341


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0000 00 01 0000
2019/20203 0000 00 00 1011
2020/202127 3301 61 01 0345
2021/202242 3003 50 14 53135
2022/202346 14147 43 15 7000
Totale 120